Selected research
Market Structure
Global Neonatal Genetic Disease Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Neonatal Genetic Disease Diagnosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Neonatal Genetic Disease Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Neonatal Genetic Disease Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Neonatal Genetic Disease Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Neonatal Genetic Disease Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Neonatal Genetic Disease Diagnosis include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd. and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Neonatal Genetic Disease Diagnosis market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Neonatal Genetic Disease Diagnosis and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Neonatal Genetic Disease Diagnosis revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Neonatal Genetic Disease Diagnosis market size, projected growth trends, production technologies, key applications, and end-use industries.
Neonatal Genetic Disease Diagnosis Segment by Company
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Neonatal Genetic Disease Diagnosis Segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Neonatal Genetic Disease Diagnosis Segment by Application
Hospital
Medical Laboratory
Others
Neonatal Genetic Disease Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Genetic Disease Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neonatal Genetic Disease Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Genetic Disease Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Neonatal Genetic Disease Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neonatal Genetic Disease Diagnosis industry.
Chapter 3: Detailed analysis of Neonatal Genetic Disease Diagnosis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neonatal Genetic Disease Diagnosisrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prenatal Diagnosis
- Screening for Single Gene Genetic Disease
- Preimplantation Genetic Testing
- Others
Applications
- Hospital
- Medical Laboratory
- Others
Companies covered
- Abbott
- PerkinElmer
- Roche Diagnostics
- Bio Rad
- Thermo Fisher Scientific
- BGI Group
- Berry Genomics
- Da An Gene Co., Ltd.
- Illumina
- CapitalBio Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Prenatal Diagnosis
- 1.2.3 Screening for Single Gene Genetic Disease
- 1.2.4 Preimplantation Genetic Testing
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Neonatal Genetic Disease Diagnosis Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Medical Laboratory
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Neonatal Genetic Disease Diagnosis Growth Trends by Region
- 1.5.1 Global Neonatal Genetic Disease Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Neonatal Genetic Disease Diagnosis Market Size by Region (2021-2026)
- 1.5.3 Neonatal Genetic Disease Diagnosis Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Neonatal Genetic Disease Diagnosis Market Dynamics
- 2.1 Neonatal Genetic Disease Diagnosis Industry Trends
- 2.2 Neonatal Genetic Disease Diagnosis Industry Drivers
- 2.3 Neonatal Genetic Disease Diagnosis Industry Opportunities and Challenges
- 2.4 Neonatal Genetic Disease Diagnosis Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Neonatal Genetic Disease Diagnosis Revenue by Company (2021-2026)
- 3.2 Global Neonatal Genetic Disease Diagnosis Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Neonatal Genetic Disease Diagnosis Key Company Head office and Area Served
- 3.4 Global Neonatal Genetic Disease Diagnosis Company, Product Type & Application
- 3.5 Global Neonatal Genetic Disease Diagnosis Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Neonatal Genetic Disease Diagnosis Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Neonatal Genetic Disease Diagnosis Players Market Share by Revenue in 2025
- 3.6.3 2025 Neonatal Genetic Disease Diagnosis Tier 1, Tier 2, and Tier 3
4 Neonatal Genetic Disease Diagnosis Market by Type
- 4.1 Global Neonatal Genetic Disease Diagnosis Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Neonatal Genetic Disease Diagnosis Market Size by Type (2021-2032)
- 4.3 Global Neonatal Genetic Disease Diagnosis Market Size Share by Type (2021-2032)
5 Neonatal Genetic Disease Diagnosis Market by Application
- 5.1 Global Neonatal Genetic Disease Diagnosis Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2032)
- 5.3 Global Neonatal Genetic Disease Diagnosis Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Abbott Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 PerkinElmer
- 6.2.1 PerkinElmer Company Information
- 6.2.2 PerkinElmer Business Overview
- 6.2.3 PerkinElmer Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 PerkinElmer Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.2.5 PerkinElmer Recent Developments
- 6.3 Roche Diagnostics
- 6.3.1 Roche Diagnostics Company Information
- 6.3.2 Roche Diagnostics Business Overview
- 6.3.3 Roche Diagnostics Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Roche Diagnostics Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.3.5 Roche Diagnostics Recent Developments
- 6.4 Bio Rad
- 6.4.1 Bio Rad Company Information
- 6.4.2 Bio Rad Business Overview
- 6.4.3 Bio Rad Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bio Rad Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.4.5 Bio Rad Recent Developments
- 6.5 Thermo Fisher Scientific
- 6.5.1 Thermo Fisher Scientific Company Information
- 6.5.2 Thermo Fisher Scientific Business Overview
- 6.5.3 Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Thermo Fisher Scientific Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.5.5 Thermo Fisher Scientific Recent Developments
- 6.6 BGI Group
- 6.6.1 BGI Group Company Information
- 6.6.2 BGI Group Business Overview
- 6.6.3 BGI Group Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 BGI Group Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.6.5 BGI Group Recent Developments
- 6.7 Berry Genomics
- 6.7.1 Berry Genomics Company Information
- 6.7.2 Berry Genomics Business Overview
- 6.7.3 Berry Genomics Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Berry Genomics Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.7.5 Berry Genomics Recent Developments
- 6.8 Da An Gene Co., Ltd.
- 6.8.1 Da An Gene Co., Ltd. Company Information
- 6.8.2 Da An Gene Co., Ltd. Business Overview
- 6.8.3 Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Da An Gene Co., Ltd. Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.8.5 Da An Gene Co., Ltd. Recent Developments
- 6.9 Illumina
- 6.9.1 Illumina Company Information
- 6.9.2 Illumina Business Overview
- 6.9.3 Illumina Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Illumina Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.9.5 Illumina Recent Developments
- 6.10 CapitalBio Technology
- 6.10.1 CapitalBio Technology Company Information
- 6.10.2 CapitalBio Technology Business Overview
- 6.10.3 CapitalBio Technology Neonatal Genetic Disease Diagnosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 CapitalBio Technology Neonatal Genetic Disease Diagnosis Product Portfolio
- 6.10.5 CapitalBio Technology Recent Developments
7 North America
- 7.1 North America Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 7.2 North America Neonatal Genetic Disease Diagnosis Market Size by Type
- 7.2.1 North America Neonatal Genetic Disease Diagnosis Market Size by Type (2021-2026)
- 7.2.2 North America Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032)
- 7.2.3 North America Neonatal Genetic Disease Diagnosis Market Share by Type (2021-2032)
- 7.3 North America Neonatal Genetic Disease Diagnosis Market Size by Application
- 7.3.1 North America Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026)
- 7.3.2 North America Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032)
- 7.3.3 North America Neonatal Genetic Disease Diagnosis Market Share by Application (2021-2032)
- 7.4 North America Neonatal Genetic Disease Diagnosis Market Size by Country
- 7.4.1 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 7.4.3 North America Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 7.4.4 North America Neonatal Genetic Disease Diagnosis Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 8.2 Europe Neonatal Genetic Disease Diagnosis Market Size by Type
- 8.2.1 Europe Neonatal Genetic Disease Diagnosis Market Size by Type (2021-2026)
- 8.2.2 Europe Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032)
- 8.2.3 Europe Neonatal Genetic Disease Diagnosis Market Share by Type (2021-2032)
- 8.3 Europe Neonatal Genetic Disease Diagnosis Market Size by Application
- 8.3.1 Europe Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026)
- 8.3.2 Europe Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032)
- 8.3.3 Europe Neonatal Genetic Disease Diagnosis Market Share by Application (2021-2032)
- 8.4 Europe Neonatal Genetic Disease Diagnosis Market Size by Country
- 8.4.1 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 8.4.3 Europe Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 8.4.4 Europe Neonatal Genetic Disease Diagnosis Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 9.2 China Neonatal Genetic Disease Diagnosis Market Size by Type
- 9.2.1 China Neonatal Genetic Disease Diagnosis Market Size by Type (2021-2026)
- 9.2.2 China Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032)
- 9.2.3 China Neonatal Genetic Disease Diagnosis Market Share by Type (2021-2032)
- 9.3 China Neonatal Genetic Disease Diagnosis Market Size by Application
- 9.3.1 China Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026)
- 9.3.2 China Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032)
- 9.3.3 China Neonatal Genetic Disease Diagnosis Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 10.2 Asia Neonatal Genetic Disease Diagnosis Market Size by Type
- 10.2.1 Asia Neonatal Genetic Disease Diagnosis Market Size by Type (2021-2026)
- 10.2.2 Asia Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032)
- 10.2.3 Asia Neonatal Genetic Disease Diagnosis Market Share by Type (2021-2032)
- 10.3 Asia Neonatal Genetic Disease Diagnosis Market Size by Application
- 10.3.1 Asia Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026)
- 10.3.2 Asia Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032)
- 10.3.3 Asia Neonatal Genetic Disease Diagnosis Market Share by Application (2021-2032)
- 10.4 Asia Neonatal Genetic Disease Diagnosis Market Size by Country
- 10.4.1 Asia Neonatal Genetic Disease Diagnosis Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 10.4.3 Asia Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 10.4.4 Asia Neonatal Genetic Disease Diagnosis Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Type
- 11.2.1 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Application
- 11.3.1 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country
- 11.4.1 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Neonatal Genetic Disease Diagnosis Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst